Product Information
PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE) is a brand product labeled by Pfizer Inc., priced at $133.5413 per EA under NDC 00069052111. Its NADAC has been published 32 times since Nov 19, 2025.
Manufacturer
Pfizer Inc.NDC
00069052111
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA217188On Market Since
4/15/2025
Price Statistics
The NADAC for PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE) has been published 32 times since Nov 19, 2025, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $133.5413 per EA |
|---|---|
| All-time high | $134.1575 (Jun 10, 2026) |
| All-time low | $130.2500 (Dec 17, 2025) |
| 52-week high | $134.1575 |
| 52-week low | $130.2500 |
| Median price | $134.1575 |
| Average price | $133.3952 |
| Largest weekly change | +3.0% (Dec 31, 2025) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE)?
The current National Average Drug Acquisition Cost (NADAC) for PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE), manufactured by Pfizer Inc., is $133.5413 per EA (NDC 00069052111), effective Jun 24, 2026.
How has the price of PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE) changed over time?
Over the history we have for it, the NADAC for PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE) has risen 2.5%. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE)?
Since Nov 19, 2025, the NADAC for PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE) has ranged from a low of $130.2500 (Dec 17, 2025) to a high of $134.1575 (Jun 10, 2026), with a median of $134.1575 per EA.
Are there cheaper alternatives to PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE)?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PAXLOVID 300-100 MG DOSE PACK, is $49.2332 per EA — about 63% below PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE).
Who manufactures PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE)?
PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE) (NDC 00069052111) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification